Skip to content

Insider · CIK 0001917672

Marwan Sabbagh

director

Files at CRVO (CervoMed Inc.). First filing -, latest -.

In brief

Marwan Sabbagh files SEC Form 4 as director at CRVO (CervoMed Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Marwan Sabbagh has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 8, 2026CRVO
CervoMed Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+8,150$0.00$08,150Jun 10, 2026
Jun 23, 2025CRVO
CervoMed Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+8,100$0.00$08,100Jun 25, 2025
Jun 14, 2024CRVO
CervoMed Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+5,750$0.00$05,750Jun 14, 2024

Questions about Marwan Sabbagh

Answered from the filings on this page, as of the latest one.

Is Marwan Sabbagh buying or selling?

Marwan Sabbagh has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Marwan Sabbagh's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marwan Sabbagh has 0.

Where does Marwan Sabbagh file Form 4?

Marwan Sabbagh has filed Form 4 at CRVO (CervoMed Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Marwan Sabbagh: insider trades and track record | InsiderTell